1 / 18

Management of Osteoarthritis of the Knee

Management of Osteoarthritis of the Knee. Anoop Agrawal, M.D. Baylor College of Medicine. Background. Knee Osteoarthritis is a slowly developing chronic disease of multifactorial origin. Risk factors include: obesity acute joint injury occupational factors (bending, lifting)

veta
Download Presentation

Management of Osteoarthritis of the Knee

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Management of Osteoarthritis of the Knee • Anoop Agrawal, M.D. • Baylor College of Medicine

  2. Background • Knee Osteoarthritis is a slowly developing chronic disease of multifactorial origin. • Risk factors include: • obesity • acute joint injury • occupational factors (bending, lifting) • genetic - although actual genes and mechanism of association is uncertain

  3. Pathogenesis Loss of articular cartilage Increased focal stress Further loss of cartilage Bony remodeling Joint Malalignment Joint Failure

  4. Diagnosis • Classic clinical criteria: developed in 1986 by an expert panel • It requires the presence of knee pain plus at least 3 of the following 6: • age >50 years • morning stiffness <30 minutes • crepitus on active motion of the knee • bony tenderness • bony enlargement • no palpable warmth

  5. Diagnosis • Classic criteria has sensitivity of 95%, specificity of 69%. • Other classification trees have been developed - some incorporate lab studies and x-ray findings along with clinical features.

  6. Classification Trees

  7. Keys to Diagnosis • Pain related to activity is the hallmark. • History of pain with activities involving knee bending indicates disease in the patellofemoral joint • History of knee giving way may indicate an associated meniscal or ACL tear. • Both of these tears are common in advanced OA • Pain at night is indicative of severe OA vs. pain from other causes (tumors, infection, inflammation)

  8. Radiography • True or False. Radiographic findings correlate poorly with the severity of pain. • True, knee films may be normal in patients with osteoarthritis Indications for x-rays in the workup of knee pain: Pain is nocturnal Pain is not activity-related Pain persists after effective therapy of OA

  9. Exam findings • On examination of the leg, is the pain being referred from the hip? • Legs should be examined for malalignment, i.e varus or valgus deformity. • Observe and record the patient’s gait - is there an antalgic gait? Does the patient use a cane? • Is there pain to palpation over the joint lines? • Perform McMurray and Lachman

  10. Laboratory Studies • No lab studies are indicated unless symptoms and signs are suggestive of other pathology. • Synovial fluid examination and serologic markers for inflammation aid in ruling out inflammatory conditions. • Synovial fluid with white cell count below 1000 is consistent with OA.

  11. Treatment • Pharmaceutical • Oral analgesics (acetaminophen, NSAIDS) • Injections of Hyaluronic Acid • Glucosamine and Chondroitin Sulfate • Intraarticular corticosteroid injections • Nonpharmaceutical • Exercise, correcting malalignment, unloading, acupuncture, yoga

  12. Oral Analgesics • Which drug is more efficacious in relieving osteoarthritic pain - NSAIDS, COX-2 inhibitors, or acetaminophen? • NSAIDS and COX-2 inhibitors - a 2006 Cochrane analysis review of 15 randomized control trials involving 5,986 patients found these agents superior to acetaminophen • However, because of NSAIDS have greater toxicity (CV, GI), the American College of Rheumatology still considers acetaminophen as first line of therapy.

  13. Oral Analgesics • Acetaminophen also appears to be less effective in patients who have already received therapy with NSAIDs. • PPIs or other GI-protective meds are increasingly being recommended for use with NSAIDs. There is no method to counter the increased cardiovascular risk other than to limit their use.

  14. Other oral agents • Tramadol is a synthetic opioid agonist that binds weakly to mu receptors. • Studies in OA patients have shown tramadol to be comparable to ibuprofen and can be used as an adjunctive in patients who are inadequately controlled with NSAIDS alone. • Opioids are the final oral agent of choice if the patient is not responding to the above therapies

  15. Other pharmaceutical agents • Injection of Hyaluronic Acid - is FDA approved for treatment of OA, however, data from large trials suggest very limited efficacy. • Glucosamine and Chondroitin Sulfate - MOA unclear; good safety profile; no clear benefit • Intraarticular corticosteroid injection - is effective in providing pain relief, duration is variable (1 week to a few months). There is no data regarding optimal number or frequency. • Topical capsaicin - modestly better than placebo

  16. Nonpharmacuetical Therapy • Exercise: specifically, muscle strengthening of quadriceps • helps to improve alignment, stability of the joint and reduces pain. • must be resistance training (isotonic) • Reduce joint-loading forces via use of canes or walkers • Correct malalignment with shoe inserts, knee braces, or neoprene sleeves

  17. Summary • OA of the knee starts with the loss of articular cartilage and results in joint failure • Diagnosis of OA is based on clinical criteria. • Radiography and laboratory testing do not assist in diagnosing OA, but rather in ruling out other disease processes. • Therapy with acetaminophen remains first line, though NSAIDS have somewhat better efficacy. • Instituting nonpharmacologic tx such as resistance training and correcting malalignment are as impotant as pain control in preventing progression.

  18. References • Felson, DT. Osteoarthritis of the Knee. New England Journal of Medicine 2006; 354:841-8. • Katz, WA. Management of Moderate Chronic Pain in Osteoarthritis. Medscape, April 27, 2006. • Kalunian, KC. Brion PH. Wollaston, SJ. Diagnosis and Classification of Osteoarthritis. UpToDate® Online 15.1; 2007. • Tauheed, T. Maxwell, L. Judd, M. et al. Acetaminophen for Osteoarthritis. Cochrane Database Systems Review 2006;(1):CD004257

More Related